Dendritic Cell Vaccine (Her2/Her3)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dendritic Cell Vaccine (Her2/Her3), covering 2026-02-12 to 2026-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer [Phase 2]